Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
In order to investigate the mechanism of thrombin inactivation in the presence of both antithrombin III (AT III) and alpha 2-macroglobulin (alpha 2 M), thrombin and the inhibitors have been purified from human material and thrombin inactivation studied using purified reagents either alone or added to defibrinated plasma. Comparison of clotting and amidolytic activities of residual thrombin allowed to measure the amount of thrombin bound to alpha 2 M. In a purified reagent system as well as in plasma, part of exogenous thrombin is bound to alpha 2 M. The amount of bound thrombin is related to alpha 2 M concentration. Conversely, previous plasma alpha 2 M depletion by immunoabsorption increases the consumption of heparin-cofactor activity by exogenous thrombi. Thus AT III and alpha 2 M compete for thrombin inactivation. This finding could be of practical interest in clinical situations associating high plasma alpha 2 M levels and a decrease of AT III concentrations.
D000990:Antithrombin III / Q000378:metabolism* / Q000494:pharmacology; D001667:Binding, Competitive; D001777:Blood Coagulation; D004305:Dose-Response Relationship, Drug; D006801:Humans; D066298:In Vitro Techniques; D013917:Thrombin / Q000378:metabolism*; D000511:alpha-Macroglobulins / Q000378:metabolism* / Q000494:pharmacology
D000511:alpha-Macroglobulins; D000990:Antithrombin III; D013917:Thrombin